By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement.
Cookie Disclaimer
We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the app and the website, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalized content. You are free to decide in the Cookie Settings which categories you would like to permit. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Statement.
Cookie Disclaimer
These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.
These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., setting the language).
These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.
{"analytics":"targeting","share":"targeting"}
Disclaimer
Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of
Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD.
Announcing the newly formed Global Health Institute
Publish Date
18 APR 2017
ShareIcons revealed to the left
Overview
Our company Furthers Commitment Towards Elimination of Schistosomiasis Through the Global Health Institute and a new Public-Private Partnership
In the context of its activities to deliver integrated health solutions for vulnerable populations suffering from infectious diseases, our company has formed a new public-private partnership for the next three years with the Australian Institute of Tropical Health and Medicine (James Cook University, Queensland) and Baylor College of Medicine (Texas, USA). This partnership, awarded grant from Austrade (Australian government's agency), aims to develop new diagnostics essential to determine all schistosomiasis patients in need of treatment. The project is part of the portfolio of the newly announced Global Health Institute. Press release
